Evidence map›Paper›PMID 37053552›Full record

ArticleBlood2023

IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria.

Carmelo Gurnari, Pedro Henrique Prata, Luiz Fernando B Catto, Arda Durmaz, Lise Larcher, Marie Sebert, Vincent Allain, Tariq Kewan, Simona Pagliuca, Andre L Pinto and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Carmelo GurnariTranslational Hematology and Oncology Research Department of Cleveland Clinic, Cleveland, OH.ORCID 0000-0001-6829-5544
Pedro Henrique PrataUniversity of Paris, Paris, France.ORCID 0000-0003-0235-7890
Luiz Fernando B CattoDepartment of Medical Imaging, Hematology and Oncology, University of São Paulo, Riberão Preto, Brazil.ORCID 0000-0002-4019-3850
Arda DurmazTranslational Hematology and Oncology Research Department of Cleveland Clinic, Cleveland, OH.ORCID 0000-0001-8394-600X
Lise LarcherUniversity of Paris, Paris, France.ORCID 0000-0002-9461-0728
Marie SebertINSERM U944/CNRS UMR7212, Institut de Recherche Saint-Louis, Paris, France.
Vincent AllainUniversity of Paris, Paris, France.
Tariq KewanTranslational Hematology and Oncology Research Department of Cleveland Clinic, Cleveland, OH.
Simona PagliucaTranslational Hematology and Oncology Research Department of Cleveland Clinic, Cleveland, OH.ORCID 0000-0003-4688-2478
Andre L PintoDepartment of Medical Imaging, Hematology and Oncology, University of São Paulo, Riberão Preto, Brazil.ORCID 0000-0002-0900-0504
Mariana C B InacioDepartment of Medical Imaging, Hematology and Oncology, University of São Paulo, Riberão Preto, Brazil.
Lucie HernandezUniversity of Paris, Paris, France.
Nathalie DhedinHematology Adolescents and Young Adults, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Sophie Caillat-ZucmanUniversity of Paris, Paris, France.ORCID 0000-0002-4535-3550
Emmanuelle ClappierINSERM U944/CNRS UMR7212, Institut de Recherche Saint-Louis, Paris, France.
Flore Sicre de FontbruneHematology and Transplantation Unit, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID 0000-0003-2000-1556
Maria Teresa VosoDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0002-6164-4761
Valeria VisconteTranslational Hematology and Oncology Research Department of Cleveland Clinic, Cleveland, OH.
Régis Peffault de LatourUniversity of Paris, Paris, France.
Jean SoulierUniversity of Paris, Paris, France.
Gérard SociéUniversity of Paris, Paris, France.
Rodrigo T CaladoDepartment of Medical Imaging, Hematology and Oncology, University of São Paulo, Riberão Preto, Brazil.ORCID 0000-0002-7966-6029
Jaroslaw P MaciejewskiTranslational Hematology and Oncology Research Department of Cleveland Clinic, Cleveland, OH.

Funding

Therapeutic Implications of Molecular Defects in Bone Marrow FailureR35HL135795 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MACIEJEWSKI, JAROSLAW P. · 2017 to 2023
$5.7M
NHLBI NIH HHS R35 HL135795
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, AplasticHemoglobinuria, ParoxysmalMyelodysplastic SyndromesNeoplasmsHumans

Identifiers

PMID37053552
PMCPMC10315616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.